Tony Yang, ScD, LLM, MPH

Articles by Tony Yang, ScD, LLM, MPH

After Refusal-to-File, FDA Reconsiders Moderna’s mRNA Flu Vaccine With Higher Bar for Older Adults

ByKennedy Ferruggia, Associate Editor,Tony Yang, ScD, LLM, MPH

February 18th 2026

The FDA accepts Moderna’s mRNA flu vaccine filing, targeting adults 50 years and older, with an accelerated path for older adults and a 2026 decision deadline.

Latest Updated Articles

After Refusal-to-File, FDA Reconsiders Moderna’s mRNA Flu Vaccine With Higher Bar for Older Adults
February 18th 2026

Tony Yang, ScD, LLM, MPH

Articles by Tony Yang, ScD, LLM, MPH

After Refusal-to-File, FDA Reconsiders Moderna’s mRNA Flu Vaccine With Higher Bar for Older Adults

Latest Updated Articles

Trending on Pharmacy Times

Could CAR T Therapy Become Adjustable After Infusion?

Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC